DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 2.36% to $2.17 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.32% to 19,460.49 and the Dow Jones Industrial Average falling 0.22% to 42,427.74.
This was the stock's third consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 82.40% short of its 52-week high of $12.33, which the company reached on July 26th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.78% to $153.22, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.17% to $23.39.
Trading volume (728,796) eclipsed its 50-day average volume of 619,523.
Data source: Dow Jones Market Data, FactSet. Data compiled June 4, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 04, 2025 17:28 ET (21:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。